Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Davis Polk Advises Lar España Real Estate SOCIMI, S.A. on Its €135 Million Equity Offering
Davis Polk advised Lar España Real Estate SOCIMI, S.A. (Lar España) as to U.S. and English law in connection with its…
Merlin Properties SOCIMI, S.A. €1 Billion Equity Offering
Davis Polk advised the underwriters as to U.S. law in connection with the offering by Merlin Properties SOCIMI, S.A. (Merlin…
The Export-Import Bank of Korea Notes Offering
Davis Polk advised the underwriter in connection with a concurrent SEC-registered Schedule B debt offering by KEXIM of US…
Davis Polk Advises Solvay on Its Acquisition of Cytec
Davis Polk is advising Solvay SA in connection with its $6.4 billion acquisition of Cytec Industries Inc. Under the terms of…
Imperial Tobacco $4.5 Billion Notes Offering
Davis Polk advised the joint bookrunners in connection with a Rule 144A/Regulation S offering by Imperial Tobacco Finance…
Davis Polk Advises Capio AB on Its SEK2.5 Billion (US$300 Million) Initial Public Offering
Davis Polk advised Capio AB (publ) on its initial public offering and listing of shares on NASDAQ Stockholm. Assuming full…
Davis Polk Advises Pandox AB on Its SEK6.36 Billion (US$780 Million) Initial Public Offering
Davis Polk advised Pandox Aktiebolag (publ) on its initial public offering and listing of B Shares on NASDAQ Stockholm…
Nordax Group AB (publ)’s SEK2.85 Billion Initial Public Offering
Davis Polk advised the joint global coordinators, joint bookrunners and co-lead manager in the initial public offering of 57…
Biotie Therapies Corp. Initial Public Offering
Davis Polk advised Biotie Therapies Corp. (“Biotie”) on its $56.7 million U.S. initial public offering of 3,806,047 American…
Merger of Vedanta Limited and Cairn India Limited
Davis Polk advised the financial adviser to Vedanta Limited (“Vedanta”) in connection with its proposed recommended merger…